Literature DB >> 27725235

Histologic Abnormalities in Non-neoplastic Renal Parenchyma and the Risk of Chronic Kidney Disease Following Radical Nephrectomy.

Ricardo Brandina1, Katia Ramos Moreira Leite2, Emerson Pereira Gregório2, Karen Barros Parron Fernandes2, Miguel Srougi2.   

Abstract

OBJECTIVE: To assess the association of histopathological parameters in non-neoplastic renal parenchyma with the development of new-onset chronic kidney disease (CKD) after radical nephrectomy. PATIENTS AND METHODS: Data were extracted from 222 patients who underwent radical nephrectomy. The Modification of Diet in Renal Disease formula was used. The study end point was development of CKD, defined as an estimated glomerular filtration rate (eGFR) of less than 60 mL/min/1.73 m2. A renal pathologist assessed three histologic features in the non-neoplastic parenchyma, namely global glomerulosclerosis (GS), arteriosclerosis (AS), and interstitial fibrosis (IF). For GS assessment, the percent of affected glomeruli was determined. AS was graded and divided into three groups, namely 1-0%-25%, 2-26%-50%, and 3-greater than 50%. IF was evaluated as absent or present.
RESULTS: After a mean follow-up of 49.06 months, the mean eGFR rate decrease was 26.5% after radical nephrectomy. Almost half of the patients (53.8%) developed CKD. For each 2.5% increase in GS, each point increase in Charlson comorbidity index (CCI), and each 10-year increase in patient's age, the eGFR decreased 28%, 33%, and 39%, respectively (P < .05). In a univariate analysis, age, CCI, GS, AS, IF, hypertension, and diabetes mellitus were associated with new-onset CKD after radical nephrectomy (P < .05). After multivariate logistic regression, CCI, GS, and baseline eGFR were associated with new-onset CKD after radical nephrectomy.
CONCLUSION: Histopathological evaluation of non-neoplastic renal parenchyma in patients who undergo radical nephrectomy can be used to predict the development of new-onset CKD.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27725235     DOI: 10.1016/j.urology.2016.09.041

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  A Higher Foci Density of Interstitial Fibrosis and Tubular Atrophy Predicts Progressive CKD after a Radical Nephrectomy for Tumor.

Authors:  Luisa Ricaurte Archila; Aleksandar Denic; Aidan F Mullan; Ramya Narasimhan; Marija Bogojevic; R Houston Thompson; Bradley C Leibovich; S Jeson Sangaralingham; Maxwell L Smith; Mariam P Alexander; Andrew D Rule
Journal:  J Am Soc Nephrol       Date:  2021-06-18       Impact factor: 14.978

2.  Larger Nephron Size and Nephrosclerosis Predict Progressive CKD and Mortality after Radical Nephrectomy for Tumor and Independent of Kidney Function.

Authors:  Aleksandar Denic; Hisham Elsherbiny; Aidan F Mullan; Bradley C Leibovich; R Houston Thompson; Luisa Ricaurte Archila; Ramya Narasimhan; Walter K Kremers; Mariam P Alexander; John C Lieske; Lilach O Lerman; Andrew D Rule
Journal:  J Am Soc Nephrol       Date:  2020-09-16       Impact factor: 10.121

3.  Pathologic analysis of non-neoplastic parenchyma in renal cell carcinoma: a comprehensive observation in radical nephrectomy specimens.

Authors:  Xun Wang; Qiang Liu; Wen Kong; Jiwei Huang; Yonghui Chen; Yiran Huang; Jin Zhang
Journal:  BMC Cancer       Date:  2017-12-28       Impact factor: 4.430

4.  Association of Ancillary Pathology Findings in Non-neoplastic Renal Parenchyma and Renal Outcomes of Robotic-Assisted Partial Nephrectomy.

Authors:  Laura E Geldmaker; Amanda E Kahn; Kevin A Parikh; Ivan E Porter; Daniela A Haehn; Essa M Bajalia; Qihui Zhai; Colleen T Ball; David D Thiel
Journal:  Front Surg       Date:  2021-04-16

5.  More than ancillary records: clinical implications of renal pathology examination in tumor nephrectomy specimens.

Authors:  Johannes Philipp Kläger; Ahmad Al-Taleb; Mladen Pavlovic; Andrea Haitel; Eva Comperat; Harun Fajkovic; Željko Kikić; Renate Kain; Nicolas Kozakowski
Journal:  J Nephrol       Date:  2021-04-22       Impact factor: 3.902

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.